Purchase Order 75N92024P00032
Award Date
12/1/23
Potential Completion Date
3/31/24
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Biolegend, Inc.
Ultimate Awardee
Revvity Inc.
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,041.90 purchase order to Biolegend, Inc., a medical division of Revvity Inc., for BIOLEGEND ANTIBODIES. The firm fixed price order runs from September 1, 2023 through October 31, 2023 for place of performance in San Diego, California. No major subcontractors or set aside designations were indicated. This small purchase supports the NIH/NIAID's research...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives...
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
This is a firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract, valued at $11,120.50, is to provide antibodies to the NHLBI's Division of Intramural Research, Center for Comparative Medicine and Pathobiology, to assess antigens on the surface...
This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Biolegend, Inc. for $21,586.50. The contract is to procure BioLegend's TOTALSEQ antibodies and associated solutions to support single cell RNA sequencing of cerebrospinal fluid samples as part of the agency's ongoing research into characterizing immune cells in multiple sclerosis patients. Only BioLegend can provide the oligonucleotide-tagged...
This $13,265.25 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the supply of antibodies and kits to support cell isolation research that may affect the immune system. Biolegend is a specialized supplier of products used in immunology, oncology, neuroscience, and cell biology...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $102,869.00 firm fixed price purchase order contract to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract is for the provision of various TotalSeq antibody products including antibody panels, oligonucleotide-tagged antibodies, and other reagents compatible with single...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $21,863.25 to Biolegend, Inc. for BIOLEGEND TOTALSEQ ANTIBODIES. No set-aside designation was used. Performance will occur in San Diego, California with a completion date of May 7, 2024. Biolegend, Inc. is a subsidiary of Revvity Inc.'s Medical Imaging, LLC division. The award is likely associated with research efforts...